A Comparative Study of Monopolar Versus Bipolar Electrocautery Post Tonsillectomy Outcomes.

NCT07265531 | Active Not Recruiting

• 1 other identifier: IHHN_IRB_2024_12_021
• Study Type: observational
• Target: 74
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare surgical techniques (monopolar and bipolar electrocautery -used during tonsillectomy,a common procedure to remove toonsils.The goal is to determine which method results in less pain and bleeding for patients after surgery .

Conditions

Chronic Tonsillitis

Keywords

MVBETO

Outcome Measures

Primary Outcomes (1)

• Post operative pain and bleeding in patient undergone tonsillectomy

  Postoperative Bleeding: Occurrence of postoperative reactionary and secondary bleeding Reactionary bleeding: If bleeding occurs within the first 24 hours after surgery. Secondary bleeding: If bleeding occurs beyond 24 hours within 7-10 days after surgery. Pain: Pain will be evaluated by Visual analog score on 1st postoperative day,3rd postoperative day and 7th post operative, visual analog score will be 0 (no pain)1 to 3 (mild),3 to 6(moderate),6 to 9 (severe),10(worst).

  24 hours after surgery and beyond 24 hours

Eligibility Criteria

• Age: 5 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

The frequent patients are children

You may qualify if:

• Patients aged between 5 and 40 years.
• Indicated for elective tonsillectomy due to recurrent tonsillitis, obstructive sleep apnea, or chronic tonsillar hypertrophy.
• Medically stable to undergo general anesthesia and surgical procedure.
• Ability to understand and provide informed consent (or parental/guardian consent for minors).

You may not qualify if:

• History of bleeding disorders (e.g., hemophilia, thrombocytopenia).
• Use of anticoagulants or antiplatelet therapy within 7 days prior to surgery.
• Known allergy or adverse reaction to anesthesia agents used in the procedure.
• Previous tonsillar surgery or peritonsillar abscess drainage.
• Severe comorbidities that may interfere with surgery or recovery (e.g., uncontrolled diabetes, heart failure).
• Patients with craniofacial abnormalities affecting the airway.
• Inability to understand or comply with study requirements.

Sponsors & Collaborators

• Indus Hospital and Health Network: lead

Study Sites (1)

Indus Hospital Karachi

Karachi, Sindh, 75500, Pakistan

Location

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 10 Days
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr Dureshahwar

Study Record Dates

• First Submitted: September 19, 2025
• First Posted: December 5, 2025
• Study Start: July 20, 2025
• Primary Completion: May 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: December 5, 2025

Record last verified: 2025-09

Locations

PA (1)